About Neurology
There are 4.17K companies in the Neurology sector across the world, with 2.57K funded companies having collectively raised $80.6B in venture capital money and private equity. Overall 1.18K of these are Series A+ funded and the sector has seen the creation of 8 Unicorns.
Neurology sector has seen 292 acquisitions and 287 IPOs. This represents almost 13.9% of all such companies - which is higher than the 4.0% exit rate of tech companies in general.
This sector includes companies engaged in R&D for developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of Neurological disorders.
Neurology sector is also known as Neurology Devices, CNS Therapeutics or Neurology.
Companies included in Neurology sector
Medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of neurological disorders.Companies excluded in Neurology sector
Healthcare Service Providers, Digital Health Solutions (software, apps, online platforms)Market Map of Neurology
The market map of Neurology gives a visual overview of the sector, showing key business models, their interactions in the value chain, and industry evolution. Trending business models in Neurology sector are At Home Diagnostics and Neurological Diagnostics.
Reports related to Neurology
Here are some reports related to Neurology sector:
Free
Neurology - Sector Report
Edition: September, 2026 (73 Pages)
Premium
Neurology Investor Landscape
Edition: March, 2025 (12 Pages)
Premium
Neurology Exit Landscape
Edition: August, 2026 (15 Pages)
View all reports related to Neurology. Sign up today!Top Companies in Neurology
There are more than 4.17K companies in Neurology. Jazz Pharmaceuticals is the top Neurology company globally, ranked using Tracxn Score (what's this?).
Here are 5 of the top Neurology companies globally:
Company | Description | Location | Founded | Current Stage | Private Funding Raised |
|---|---|---|---|---|---|
Developer of novel biopharmaceutical medicines for unmet medical needs | Dublin (Ireland) | 2003 | Public | $265M | |
Developer of therapies for neurodegenerative and immunology disorders | Cambridge (United States) | 1978 | Public | $80M | |
Developer of small molecule drugs for the treatment of rare diseases | South Plainfield (United States) | 1998 | Public | $248M | |
Developer of therapies to treat neurodegenerative diseases | San Francisco (United States) | 2015 | Public | $347M | |
Developing small molecules for control mechanisms and genes regulation for the treatment of rare diseases | Cambridge (United States) | 2015 | Public | $115M |
Companies founded year-on-year in the Neurology sector
41 new startups have been founded so far in 2026 in the Neurology sector. 279 Neurology startups were founded in 2019 - this is the most number of startups founded in any year in the last 10 years.
- Total Number of Companies
Year | No. of companies |
|---|---|
2026 | 41 |
2025 | 49 |
2024 | 83 |
2023 | 82 |
2022 | 96 |
2021 | 194 |
2020 | 253 |
2019 | 279 |
2018 | 263 |
2017 | 235 |
Companies founded across countries in the Neurology sector
United States has 2,111 Neurology startups, the most by any country, followed by United Kingdom which has 245 startups and Canada which has 201.
- Total Number of Companies
Country | No. of companies |
|---|---|
United States | 2,111 |
United Kingdom | 245 |
Canada | 201 |
Israel | 147 |
China | 127 |
France | 126 |
Germany | 119 |
South Korea | 109 |
Switzerland | 85 |
India | 80 |
Stage-wise distribution of the Neurology sector
Out of the total 4,167 Neurology companies, 2,573 have secured funding. Among them, 1,181 have reached Series A or higher, and 865 to Series B or beyond.
Founded - 4,167
Funded - 2,573
Series A+ - 1,181
Series B+ - 865
Series C+ - 688
Company Stage | No. of companies |
|---|---|
Founded | 4,167 |
Funded | 2,573 |
Series A+ | 1,181 |
Series B+ | 865 |
Series C+ | 688 |
Want to know more about Neurology ? Signup and explore Tracxn for free
- 4.2K+ Total Companies
- $80.6B+ Total Funding
- 2.6K+ Funded Companies
- 285+ IPOs
- 290+ Acquisitions
- 75+ Reports
Funding Trends in the Neurology sector
Total funding year-on-year in the Neurology sector
The Neurology sector saw a total funding of more than $58.5B in the last 10 years. The most amount of funding was in 2021 at more than $8.48B. There has been a total funding of $5.94B in 2026 till date.
- Total Funding
Year | Total Funding |
|---|---|
2026 | $5.94B |
2025 | $8.32B |
2024 | $5.94B |
2023 | $5B |
2022 | $5.99B |
2021 | $8.48B |
2020 | $6.09B |
2019 | $4.21B |
2018 | $4.61B |
2017 | $3.96B |
Total funding across countries in the Neurology sector
In the last 10 years, Neurology startups in United States have recieved the highest funding among all countries - $41.1B. United Kingdom follows with $3.06B and Switzerland with $1.65B.
- Total Funding
Country | Total Funding |
|---|---|
United States | $41.1B |
United Kingdom | $3.06B |
Switzerland | $1.65B |
China | $1.31B |
Israel | $1.09B |
Canada | $950M |
France | $885M |
Spain | $384M |
Australia | $375M |
Germany | $341M |
Total funding amount raised by stage in the Neurology sector
Over the last 10 years, the Neurology sector have seen $2.04B into Seed Stage funding rounds, $22.9B into Early Stage funding rounds and $14B go into Late Stage funding rounds.
Funding Stage | Total Funding |
|---|---|
Early Stage | $22.9B |
Late Stage | $14B |
Post IPO | $11.4B |
Grant | $2.73B |
Seed Stage | $2.04B |
Debt | $2B |
PE | $442M |
Other-Equity | $40.3M |
Recent Funding Rounds in Neurology
In the year 2026, till September 2026, Neurology companies have raised $4.1B in equity funding across 143 rounds.
In the same period last year (i.e. till September 2025), Neurology companies had raised $4.47B across 147 rounds.
So, 2026 has seen a 8.13% drop in funding in Neurology companies as compared to 2025.
Here are some recent, important funding rounds in Neurology:
Company | Round Raised | Amount Raised | Funding Date | Investors |
|---|---|---|---|---|
Series B | 1656 | Sep 30, 2026 | ||
Series D | 7421 | Sep 24, 2026 | ||
Series C | 9388 | Sep 24, 2026 | ||
Series E | 9497 | Sep 23, 2026 | ||
Series B | 9238 | Sep 23, 2026 |
Top Investors in Neurology
HHS is the top investor in Neurology companies based on number of companies invested.
Here are some top investors in Neurology:
Investor | Location | Top Portfolio Companies |
|---|---|---|
Washington, DC (United States) | ||
Brussels (Belgium) | ||
Falls Church (United States) |
M&A activity in Neurology
In the year 2026, till September 2026, 17 acquisitions happened in Neurology sector. Last year, in 2025, a total of 20 acquisitions happened in Neurology sector.
Here are some recent, important acquisitions in Neurology:
Company | Acquisition Type | Acquisition Date | Acquirers |
|---|---|---|---|
Business Acquisition | Sep 10, 2026 | ||
Business Acquisition | Aug 05, 2026 | ||
Business Acquisition | Jul 16, 2026 | ||
Business Acquisition | Jun 16, 2026 | ||
Business Acquisition | Jun 01, 2026 |
Acquisition trends in Neurology
Here are the acquisition trends in Neurology:
- Total Number of Acquisitions
Year | No. of companies |
|---|---|
2026 | 17 |
2025 | 20 |
2024 | 14 |
2023 | 18 |
2022 | 22 |
2021 | 15 |
2020 | 25 |
2019 | 11 |
2018 | 21 |
2017 | 9 |
IPOs in Neurology
In the year 2026, till September 2026, 7 IPOs happened in Neurology sector.
Here are some recent, important IPOs in Neurology:
Company | IPO Date | Exchange Symbol |
|---|---|---|
Sep 09, 2026 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Aug 07, 2026 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jul 31, 2026 | National Association of Securities Dealers Automated Quotations (NASDAQ) | |
Jul 23, 2026 | Australian Securities Exchange (ASX) | |
May 08, 2026 | National Association of Securities Dealers Automated Quotations (NASDAQ) |
Colleges which produce the most Neurology companies
Companies founded by alumni from top colleges in the Neurology sector
Most number of Neurology startups have been founded by alumni from Harvard University, Massachusetts Institute of Technology and University of California (Berkeley).
College | No. of companies |
|---|---|
Harvard University | 73 |
Massachusetts Institute of Technology | 55 |
University of California (Berkeley) | 43 |
Stanford University | 37 |
University of California (Los Angeles) | 32 |
University of Cambridge | 27 |
Harvard Business School | 26 |
University of Pennsylvania | 25 |
Columbia University | 23 |
Tel Aviv University | 20 |
Total funding in companies founded by alumni from top colleges in the the Neurology sector
In the last 10 years, Harvard University graduates' Neurology companies have raised the most funding among top colleges. Massachusetts Institute of Technology alumni are second, and Stanford University alumni are third.
College | Total Funding |
|---|---|
Harvard University | $5.8B |
Massachusetts Institute of Technology | $5.28B |
Stanford University | $3.52B |
University of California (Berkeley) | $3.48B |
Duke University | $3.1B |
Harvard Business School | $2.21B |
University of California (Los Angeles) | $1.9B |
Yale University | $1.88B |
Kellogg School of Management | $1.59B |
Columbia University | $1.54B |
Top News in Neurology
•
•
•
•
Quantum BioPharma (QNTM) Receives FDA Green Light for Lucid-MS Phase 2 TestingNewMediaWire•Sep 26, 2026•Quantum Biopharma
•
SystImmune Announces FDA Clearance of IND Application for Bispecific Antibody SI-B037PR Newswire•Sep 22, 2026•Systimmune
•
Eledon Pharmaceuticals Receives FDA Fast Track Designation for Tegoprubart in Kidney TransplantationGlobeNewswire•Sep 22, 2026•Eledon
•
FDA Approves IntraBio’s Aqneursa as First Treatment for Ataxia-TelangiectasiaContract Pharma•Sep 22, 2026•IntraBio
•
PureTech Health PLC Announces FDA Progress for LYT-200 Blood Cancer TreatmentShareprices•Sep 21, 2026•PureTech Health
•
Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic HearingGlobeNewswire•Sep 17, 2026•Clearmind
•
Flow Neuroscience Launches FDA-Approved FL-100 in US for At-Home Depression TreatmentGlobeNewswire•Sep 17, 2026•Flow Neuroscience
